Synthetic biology company AbSci’s recent acquisition of the artificial intelligence platform, Denovium, could help get novel therapeutics to patients more quickly
Synthetic Biology Startup Acquires AI Platform To Disrupt The Drug Industry
Read more on Forbes - Business